AXA SA (ETR:AXA)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	85,588	72,930	64,437	62,187	62,576	46,637
Market Cap Growth	34.76%	13.18%	3.62%	-0.62%	34.18%	-22.77%
Enterprise Value	140,229	123,307	105,958	105,920	103,399	91,627
PE Ratio	11.28	9.49	9.20	12.75	8.81	15.61
PS Ratio	0.92	0.80	0.75	0.72	0.51	0.42
PB Ratio	1.51	1.20	1.07	1.12	0.75	0.55
P/FCF Ratio	4.17	6.40	18.03	7.49	10.13	1.86
P/OCF Ratio	4.08	6.14	16.14	7.14	9.59	1.83
EV/Sales Ratio	1.50	1.35	1.24	1.22	0.85	0.82
EV/EBITDA Ratio	-	-	-	12.78	9.75	13.84
EV/EBIT Ratio	13.24	11.80	11.99	14.28	10.62	16.83
EV/FCF Ratio	6.84	10.81	29.66	12.75	16.74	3.64
Debt / Equity Ratio	1.17	1.02	0.99	1.15	0.74	0.77
Debt / EBITDA Ratio	-	-	-	7.68	5.77	9.91
Debt / FCF Ratio	3.22	5.45	16.66	7.66	9.91	2.61
Quick Ratio	2.44	1.26	1.43	1.01	0.28	0.27
Current Ratio	5.15	1.93	2.08	1.71	0.56	0.60
Asset Turnover	0.14	0.14	0.13	0.12	0.16	0.14
Return on Equity (ROE)	12.97%	12.47%	12.19%	7.52%	8.92%	3.95%
Return on Assets (ROA)	1.00%	1.01%	0.86%	0.66%	0.77%	0.43%
Return on Capital (ROIC)	5.32%	5.39%	4.63%	3.52%	4.12%	2.32%
Earnings Yield	8.86%	10.81%	11.16%	8.14%	11.66%	6.78%
Earnings Yield	8.86%	10.81%	11.16%	8.14%	11.66%	6.78%
FCF Yield	23.96%	15.63%	5.54%	13.36%	9.87%	53.92%
Dividend Yield	5.04%	6.61%	7.51%	7.70%	7.43%	9.77%
Payout Ratio	63.76%	60.35%	58.20%	78.36%	51.47%	55.09%
Buyback Yield / Dilution	0.08%	1.83%	2.57%	3.81%	-0.04%	0.08%
Total Shareholder Return	5.11%	8.44%	10.08%	11.51%	7.38%	9.86%

Updated Mar 19, 2025. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.